Page 427 - Read Online

Davis et al. Neuroimmunol Neuroinflammation 2018;5:50 I http://dx.doi.org/10.20517/2347-8659.2018.60 Page 11 of 11

sepsis. Neuropathol Appl Neurobiol 2018; doi: 10.1111/nan.12502.
50. Davis RL, Dertien J, Syapin PJ. Ethanol-induced modulation of inducible nitric-oxide synthase activity in human A172 astrocytoma
cells. Alcohol Clin Exp Res 2002;26:1404-11.
51. Sanchez AC, Davis RL, Syapin PJ. Identification of cis-regulatory regions necessary for robust Nos2 promoter activity in glial cells:
indirect role for NF-kappaB. J Neurochem 2003;86:1379-90.
52. Sominsky L, De Luca S, Spencer SJ. Microglia: key players in neurodevelopment and neuronal plasticity. Int J Biochem Cell Biol
2018;94:56-60.
53. Jadhav VS, Krause KH, Singh SK. HIV-1 Tat C modulates NOX2 and NOX4 expressions through miR-17 in a human microglial cell
line. J Neurochem 2014;131:803-15.
54. Branca JJ, Morucci G, Malentacchi F, Gelmini S, Ruggiero M, et al. Effects of oxaliplatin and oleic acid Gc-protein-derived
macrophage-activating factor on murine and human microglia. J Neurosci Res 2015;93:1364-77.
55. Bain CC, Bravo-Blas A, Scott CL, Perdiguero EG, Geissmann F, et al. Constant replenishment from circulating monocytes maintains
the macrophage pool in the intestine of adult mice. Nat Immunol 2014;15:929-37.
56. Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, et al. Identification of a unique TGF-beta-dependent molecular and
functional signature in microglia. Nat Neurosci 2014;17:131-43.
57. Zhu C, Kros JM, van der Weiden M, Zheng P, Cheng C, et al. Expression site of P2RY12 in residential microglial cells in astrocytomas
correlates with M1 and M2 marker expression and tumor grade. Acta Neuropathol Commun 2017;5:4.
58. Lokensgard JR, Mutnal MB, Prasad S, Sheng W, Hu S. Glial cell activation, recruitment, and survival of B-lineage cells following
MCMV brain infection. J Neuroinflammation 2016;13:114.
59. Sanfilippo C, Pinzone MR, Cambria D, Longo A, Palumbo M, et al. OAS gene family expression is associated with HIV-related
neurocognitive disorders. Mol Neurobiol 2018;55:1905-14.
60. Mehla R, Bivalkar-Mehla S, Nagarkatti M, Chauhan A. Programming of neurotoxic cofactor CXCL-10 in HIV-1-associated dementia:
abrogation of CXCL-10-induced neuro-glial toxicity in vitro by PKC activator. J Neuroinflammation 2012;9:239.
61. Gyoneva S, Ransohoff RM. Inflammatory reaction after traumatic brain injury: therapeutic potential of targeting cell-cell communication
by chemokines. Trends Pharmacol Sci 2015;36:471-80.
62. Davis RL, Stevens CW, Thomas Curtis J. The opioid antagonist, beta-funaltrexamine, inhibits lipopolysaccharide-induced
neuroinflammation and reduces sickness behavior in mice. Physiol Behav 2017;173:52-60.
63. Timper K, Denson JL, Steculorum SM, Heilinger C, Engstrom-Ruud L, et al. IL-6 Improves energy and glucose homeostasis in obesity
via enhanced central IL-6 trans-signaling. Cell Rep 2017;19:267-80.
64. Wei H, Alberts I, Li X. Brain IL-6 and autism. Neuroscience 2013;252:320-5.
65. Furtado M, Katzman MA. Examining the role of neuroinflammation in major depression. Psychiatry Res 2015;229:27-36.
66. Engler H, Brendt P, Wischermann J, Wegner A, Rohling R, et al. Selective increase of cerebrospinal fluid IL-6 during experimental
systemic inflammation in humans: association with depressive symptoms. Mol Psychiatry 2017;22:1448-54.
67. Lindqvist D, Hall S, Surova Y, Nielsen HM, Janelidze S, et al. Cerebrospinal fluid inflammatory markers in Parkinson’s disease--
associations with depression, fatigue, and cognitive impairment. Brain Behav Immun 2013;33:183-9.
68. Chen SY, Chen TF, Lai LC, Chen JH, Sun Y, et al. Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased
risk of late-onset Alzheimer’s disease. J Neuroinflammation 2012;9:21.
69. Spooren A, Kolmus K, Laureys G, Clinckers R, De Keyser J, et al. Interleukin-6, a mental cytokine. Brain Res Rev 2011;67:157-83.
70. Yuan T, Li Z, Li X, Yu G, Wang N, et al. Lidocaine attenuates lipopolysaccharide-induced inflammatory responses in microglia. J Surg
Res 2014;192:150-62.
71. Weng L, Zhang H, Li X, Zhan H, Chen F, et al. Ampelopsin attenuates lipopolysaccharide-induced inflammatory response through the
inhibition of the NF-kappaB and JAK2/STAT3 signaling pathways in microglia. Int Immunopharmacol 2017;44:1-8.
72. Choi MJ, Lee EJ, Park JS, Kim SN, Park EM, et al. Anti-inflammatory mechanism of galangin in lipopolysaccharide-stimulated
microglia: critical role of PPAR-gamma signaling pathway. Biochem Pharmacol 2017;144:120-31.
73. Yang C, Yu L, Kong L, Ma R, Zhang J, et al. Pyrroloquinoline quinone (PQQ) inhibits lipopolysaccharide induced inflammation in part
via downregulated NF-kappaB and p38/JNK activation in microglial and attenuates microglia activation in lipopolysaccharide treatment
mice. PLoS One 2014;9:e109502.